home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

1,221 rows where filing_year = 2023 and issue_code = "MED" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, is_termination, received_date (date)

filing_period 4

  • fourth_quarter 311
  • second_quarter 310
  • third_quarter 301
  • first_quarter 299

issue_code 1

  • MED · 1,221 ✖

filing_year 1

  • 2023 · 1,221 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
2954067 HEALTHCARE LEGAL RESOURCES NETWORK, LLC 839d6d70-0954-4b63-9301-6462cf88cb6c 1A HEALTHCARE LEGAL RESOURCES NETWORK, LLC 401107302 HEALTHCARE LEGAL RESOURCES NETWORK, LLC 2023 first_quarter MED Pharmaceutical SENATE     0 0 2023-02-16T16:08:35-05:00
2954436 FRANCIS EDWARD & CRONIN, INC. b71e6b5f-24b1-4fcb-82c6-453927dbbf86 Q1 FRANCIS EDWARD & CRONIN, INC. 311314 CURE ALZHEIMER'S FUND 2023 first_quarter MED Legislation related to Alzheimer's disease research Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2023-04-01T14:01:26-04:00
2954437 FRANCIS EDWARD & CRONIN, INC. f151587f-495e-4bb2-8f01-76760b6d7404 Q1 FRANCIS EDWARD & CRONIN, INC. 311314 PATH DECISION SUPPORT SOFTWARE, LLC 2023 first_quarter MED Legislation related to Diabetes Treament HOUSE OF REPRESENTATIVES,SENATE     0 0 2023-04-01T14:04:50-04:00
2954457 MARSHALL BRACHMAN 57deaebd-c00c-4d2a-a122-668b8323731a Q1 MARSHALL BRACHMAN 6848 BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM 2023 first_quarter MED support funding for medical research programs HOUSE OF REPRESENTATIVES,SENATE 33000   0 0 2023-04-01T17:14:08-04:00
2954534 OLD NORTH STRATEGIES, LLC 8c8724d0-9648-4e29-831d-000f190e0685 Q1 OLD NORTH STRATEGIES, LLC 401106174 EXELA PHARMA SCIENCES, LLC 2023 first_quarter MED supply chain & FDA issues HOUSE OF REPRESENTATIVES,SENATE 78000   0 0 2023-04-02T20:43:21-04:00
2954586 PENN AVENUE PARTNERS 1eadab89-9a43-4d85-8e7d-2f6af5c9767f Q1 PENN AVENUE PARTNERS 400918672 CLIFFSIDE LABS, LLC 2023 first_quarter MED Policy and regulatory matters related to the clinical laboratory industry. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2023-04-03T12:23:02-04:00
2954654 MAGILL ASSOCIATES, LLC 43cf3921-8137-4f70-8f2a-89475f4b828b Q1 MAGILL ASSOCIATES, LLC 401103511 THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES 2023 first_quarter MED FY 2023 and FY 2024 appropriations for the development of a synthetic vaccine Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2023-04-03T14:07:10-04:00
2954717 HELIX, INC. f881ca40-7f08-4056-9c51-c12171e7934b Q1 HELIX, INC. 401106164 HELIX, INC. 2023 first_quarter MED COVID-19, other respiratory pathogen sequencing and countermeasure development Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office   40000 0 0 2023-04-03T15:17:07-04:00
2954793 AUBURN HEALTH STRATEGIES, LLC e9f0c1d6-b4ba-478b-8e6d-c663b3401960 Q1 AUBURN HEALTH STRATEGIES, LLC 292697 AMERICAN PROFICIENCY INSTITUTE 2023 first_quarter MED proficiency testing for clinical laboratories Health & Human Services, Dept of (HHS)     0 0 2023-04-03T17:42:31-04:00
2954823 OCAL LOBBYING GROUP b676f214-cf09-4fbf-882a-2d12b2d8e581 Q1 OCAL LOBBYING GROUP 401106825 SAMERA S.A. 2023 first_quarter MED Obtain funding for Tuberculosis monitoring. Natl Institutes of Health (NIH)     0 0 2023-04-04T06:50:37-04:00
2954933 THE HARRIS FIRM 981401f4-82eb-4a58-af91-7513ea5b9914 Q1 THE HARRIS FIRM 68376 HOLISTIC INDUSTRIES INC. 2023 first_quarter MED Issues pertaining to cannabis CSA scheduling. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2023-04-04T13:36:30-04:00
2954955 UNIVERSITY OF MARYLAND, BALTIMORE (UMB) ea7987a2-821b-420d-aa02-6080eb47367e Q1 UNIVERSITY OF MARYLAND, BALTIMORE (UMB) 401103161 UNIVERSITY OF MARYLAND, BALTIMORE (UMB) 2023 first_quarter MED ARPA-H, budget and agency location Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   10000 0 0 2023-04-04T15:22:28-04:00
2955045 WATKINS & EAGER PLLC b5ac3baa-373c-48bc-94e6-5921238710e6 Q1 WATKINS & EAGER PLLC 401104403 NATIONAL FRAGILE X FOUNDATION 2023 first_quarter MED Assist in matters necessary for Advocacy Day planning on The Hill; Arrange meetings and appointments for NFXF officials; Work to encourage Members to act favorably on matters of interest and benefit to NFXF; Encourage Members to meet with constituents impacted by Fragile X. HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2023-04-05T11:04:52-04:00
2955123 AMERICAN COLLEGE OF CLINICAL PHARMACY fee4884b-f8ab-4153-b647-dc455ca8969f Q1 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2023 first_quarter MED Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   144981 0 0 2023-04-05T13:39:08-04:00
2955588 REPUBLIC CONSULTING, LLC 5f565610-696f-4b2e-988f-4026cd1f26e9 Q1 REPUBLIC CONSULTING, LLC 401016871 IQVIA 2023 first_quarter MED Monitor Health Data Policy. Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2023-04-06T15:41:57-04:00
2955872 DAVID GENCARELLI 35957d87-cd93-4e2c-a691-81d3fcf2ec70 Q1 DAVID GENCARELLI 15918 SANOTIZE RESEARCH & DEVELOPMENT CORPORATION 2023 first_quarter MED Outreach to Department of Defense Military Research Military Command (MRDC),HHS and National INstitute of Allergy & Infectious Disease (NIAID) Defense Threat Reduction Agency (DTRA) 18000   0 0 2023-04-07T15:13:57-04:00
2956327 AMERICAN ASSOCIATION FOR CANCER RESEARCH 5faad9bd-2dce-4a48-936e-693fa2981141 Q1 AMERICAN ASSOCIATION FOR CANCER RESEARCH 400601833 AMERICAN ASSOCIATION FOR CANCER RESEARCH 2023 first_quarter MED Cancer research generally Increasing diversity in clinical trials Drug approval Pediatric cancer detection, treatment, and prevention HOUSE OF REPRESENTATIVES,SENATE   100000 0 0 2023-04-10T11:47:03-04:00
2957030 IMPACT MANAGEMENT GROUP ab1d0986-3c1e-422a-922a-2641566e5147 Q1 IMPACT MANAGEMENT GROUP 401104137 ARKANSAS RESEARCH ALLIANCE 2023 first_quarter MED On behalf of client support continued and future funding for clinical research programs in Arkansas HOUSE OF REPRESENTATIVES,SENATE     0 0 2023-04-11T12:23:21-04:00
2957037 THE PETRIZZO GROUP, INC. e4f75591-c31b-491e-b9a0-684bcca6b7ea Q1 THE PETRIZZO GROUP, INC. 305932 OMEROS CORPORATION 2023 first_quarter MED Separate payment policies for non-opioid alternatives. HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2023-04-11T12:28:20-04:00
2957122 SQUIRE PATTON BOGGS 505f05b7-f1b0-4e9e-8c9d-9646af9104d9 Q1 SQUIRE PATTON BOGGS 30906 NATIONAL CANNABIS ROUNDTABLE 2023 first_quarter MED Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use. HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of,White House Office 80000   0 0 2023-04-11T13:56:59-04:00
2957164 BEN BARNES GROUP LP eebd3e7a-8466-4586-ace8-508f3f468614 Q1 BEN BARNES GROUP LP 5415 HUNTSMAN CORPORATION 2023 first_quarter MED CMS Medicare HOUSE OF REPRESENTATIVES,SENATE 18750   0 0 2023-04-11T14:14:48-04:00
2957184 BEN BARNES GROUP LP d750eb62-08de-475e-9ed3-012f68286a38 Q1 BEN BARNES GROUP LP 5415 ENVIGO RMS LLC 2023 first_quarter MED Medical/Disease Research HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2023-04-11T14:23:25-04:00
2957188 BEN BARNES GROUP LP 39efe2cc-20ab-419d-bb29-c054ca3c746e 1T BEN BARNES GROUP LP 5415 VIRON THERAPEUTICS 2023 first_quarter MED Covid/Virus treatments Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 50000   0 1 2023-04-11T14:35:09-04:00
2957322 THE PETRIZZO GROUP, INC. a1bdea7d-92af-42d1-a659-f7dadc0b2573 Q1 THE PETRIZZO GROUP, INC. 305932 DYSAUTONOMIA INTERNATIONAL 2023 first_quarter MED Advocate for NIH research funding for dysautonomia disorders, specifically Postural Orthostatic Tachycardia Syndrome (POTS) and funding to examine the correlation between POTS and Long COVID. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2023-04-11T16:05:15-04:00
2957419 THE PETRIZZO GROUP, INC. b7ed9111-5dc8-46c7-8a12-3e1c2d1e1719 Q1 THE PETRIZZO GROUP, INC. 305932 SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION 2023 first_quarter MED Increased funding for pediatric medical research HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2023-04-11T21:29:50-04:00
2957573 PARDES BIOSCIENCES, INC. 1a12c753-97e8-4a54-a861-d35307ae0862 Q1 PARDES BIOSCIENCES, INC. 401106493 PARDES BIOSCIENCES, INC. 2023 first_quarter MED NIH funding for clinical trials Natl Institutes of Health (NIH)   120000 0 0 2023-04-12T10:25:50-04:00
2957577 PARDES BIOSCIENCES, INC. 7b178cfd-76ff-4ab0-bfa0-f3bee1a34931 2T PARDES BIOSCIENCES, INC. 401106493 PARDES BIOSCIENCES, INC. 2023 second_quarter MED NIH funding for clinical trials Natl Institutes of Health (NIH)   120000 0 1 2023-04-12T10:26:43-04:00
2957654 ALPINE ADVISORS 8182552a-e4de-47a2-98e1-6deaf1cc5181 Q1 ALPINE ADVISORS 401106595 COALITION FOR CANNABIS POLICY, EDUCATION AND REGULATION 2023 first_quarter MED Issues pertaining to government-wide federal regulation of cannabis HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2023-04-12T11:53:49-04:00
2958173 MARSHFIELD CLINIC HEALTH SYSTEM f7f26b32-58c6-41d6-badf-5db14b769eeb Q1 MARSHFIELD CLINIC HEALTH SYSTEM 57830 MARSHFIELD CLINIC HEALTH SYSTEM 2023 first_quarter MED research support, agriculture, farm safety, child care and agriculture communities HOUSE OF REPRESENTATIVES,SENATE   70000 0 0 2023-04-12T18:57:20-04:00
2958282 COVINGTON & BURLING LLP 72693b1a-5303-4b92-a13f-e33ff97c2fb9 Q1 COVINGTON & BURLING LLP 11195 SL 2T, LLC ("SMARTLABS") 2023 first_quarter MED Education and support for policies and funding to advance turnkey, co-located, on-demand pharma grade research laboratory environments, including responses to House and Senate Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPA) Re-authorization RFI's. HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2023-04-13T09:42:09-04:00
2958897 FEDERAL SOLUTIONS, LLC 868c1f2f-e626-4bb3-986f-6df4bb34255a Q1 FEDERAL SOLUTIONS, LLC 311371 MISSISSIPPI STATE UNIVERSITY 2023 first_quarter MED Labor/HHS/Education Appropriations: Provisions relating to disease research HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2023-04-13T16:32:50-04:00
2959190 THE CJR GROUP, INC. 0dfdb3b9-7edf-4a79-bf1f-05d050187676 Q1 THE CJR GROUP, INC. 288293 UNIVERSITY HOSPITALS HEALTH SYSTEM 2023 first_quarter MED Hospital at Home HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2023-04-14T09:44:10-04:00
2959338 BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) a252b86e-938d-491a-88cd-e3d086c84c51 Q1 BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) 60218 BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) 2023 first_quarter MED Gabriella Miller Kids First Act (yet to be introduced); Implementation of the Childhood Cancer STAR Act (enacted in 2022); HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   130000 0 0 2023-04-14T11:37:54-04:00
2959853 RAY C CULVER III 340b9f70-8676-46ea-a521-04a287c59169 Q1 RAY C CULVER III 11468 ARKANSAS CHILDREN'S HOSPITAL 2023 first_quarter MED Funding for USDA ARS human nutrition research funding in the House and Senate FY24 appropriations bills. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2023-04-14T19:50:55-04:00
2959871 INVIVYD, INC. 6f320e6a-fa16-4b71-9932-613f3a33ab72 Q1 INVIVYD, INC. 401106767 INVIVYD, INC. 2023 first_quarter MED education and awareness of COVID-19 therapeutics Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE 70000   0 0 2023-04-15T04:46:09-04:00
2960120 AMERICAN SOCIETY OF ADDICTION MEDICINE 75f68d6d-5516-4f19-b53e-985ec5632b18 Q1 AMERICAN SOCIETY OF ADDICTION MEDICINE 401104864 AMERICAN SOCIETY OF ADDICTION MEDICINE 2023 first_quarter MED Advocated for increased FY24 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY24 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M) Joined coalition letters supporting increased FY24 funding for a variety of other SUD-related programs in FY24 at HRSA, SAMHSA, and CDC Advocated for (S. 644/H.R. 1359) the Modernizing Opioid Treatment Access Act, which would allow specially registered opioid treatment program clinicians and addiction specialist physicians to prescribe methadone for OUD that can be picked up from pharmacies, subject to federal regulation or guidance on supply of methadone for unsupervised use. Advocated for HR 2400- the Reentry Act, which would allow states to provide Medicaid coverage to eligible individuals up to 30 days prior to release from incarceration Supported S.971 - Due Process Continuity of Care Act, which would amend title XIX of the Social Security Act to remove the Medicaid coverage exclusion for inmates in custody pending disposition of charges, and for other purposes. Worked on draft legislation that would provide Medicare coverage for evidence-based residential SUD services Worked on draft legislation that would make permanent a state plan amendment option related to Medicaid's IMD exclusion Supported H.R.1502 - Comprehensive Opioid Recovery Centers Reauthorization Act of 2023, in its entirety Advocated for removal of in-person evaluation requirement in proposed telemedicine rules by the DEA and worked on related draft legislation Advocated for changes to proposed 42 CFR Part 8 rule governing methadone for opioid use disorder Provided recommendations for the 2024 biennial national drug control strategy in a letter to the Office of National Drug Control Policy (ONDCP). ASAM suggested inclusion in the 2024 strategy, a call for the decoupling criminal penalties and personal drug use possession, implemented as part of a carefully designed set of public health and legal reforms that include strategic, soc… Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)   65000 0 0 2023-04-16T08:04:51-04:00
2960290 TIBER CREEK GROUP 66ac7d57-49e9-4c00-99fc-04349c279e10 Q1 TIBER CREEK GROUP 20744 JAZZ PHARMACEUTICALS 2023 first_quarter MED Issues related to cannabis research; issues related to the FDA; issues related to Cannabis research at Health and Human Services. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2023-04-16T16:34:53-04:00
2960387 CAPITOL COUNSEL LLC 69050538-827f-4204-a2fb-df0bb8239d52 Q1 CAPITOL COUNSEL LLC 313715 UNIVERSITY OF MASSACHUSETTS, BOSTON 2023 first_quarter MED Advocacy related to federal funding for UMass Boston for healthcare workforce and sustainability educational projects in FY 2024 Appropriations legislation. Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2023-04-16T18:16:15-04:00
2960597 BROYDRICK & ASSOCIATES 9401c6e9-ecc3-49a2-9b83-787818d89f4d Q1 BROYDRICK & ASSOCIATES 7268 NORTHSTAR RADIOISOTOPES, LLC 2023 first_quarter MED DOE policies and cooperative agreements expansion legislation, Nuclear medicine CMS Reimbursement, NNSA reorganization. Funding for new cooperative agreements. NDAA provisions. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2023-04-17T09:39:47-04:00
2960613 THE CONSILIO GROUP b34a2147-ceb4-434f-b87b-0d060d183c10 Q1 THE CONSILIO GROUP 400374717 DETECTACHEM 2023 first_quarter MED Colorimetric explosive and narcotic detection capabilities Air Force, Dept of,Defense, Dept of (DOD),Education, Dept of,Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Navy, Dept of,SENATE,White House Office 16500   0 0 2023-04-17T09:43:43-04:00
2960622 IPOLICY SOLUTIONS 577582e3-b313-4997-953d-c21ff7c85860 Q1 IPOLICY SOLUTIONS 401105127 ASSOCIATION FOR MOLECULAR PATHOLOGY 2023 first_quarter MED No bill #: Verified Innovative Testing in American Laboratories Act H.R.2369 - VALID Act of 2023 Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE 45000   0 0 2023-04-17T09:46:58-04:00
2960655 IPOLICY SOLUTIONS db1dd3c1-a59f-4938-b0d5-dcdd6900978a Q1 IPOLICY SOLUTIONS 401105127 INVITAE INC. 2023 first_quarter MED H.R.2369 - VALID Act of 2023 HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2023-04-17T09:57:47-04:00
2960752 F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES f92faf78-115a-4e7f-a973-6bed78cb5154 Q1 F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES 18411 F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES 2023 first_quarter MED (MED) Clinical Lab Fee Schedule H.R. 2377 and S. 1000. Saving Access to Laboratory Services Act HOUSE OF REPRESENTATIVES,SENATE   150000 0 0 2023-04-17T10:23:52-04:00
2960787 EMERGENT STRATEGIES 53ecd670-9924-4ce9-823d-a7709fcad12b Q1 EMERGENT STRATEGIES 401104778 ADVAMED:ADVANCED MEDICAL TECHNOLOGY ASSOCIATION 2023 first_quarter MED Health tax issues and trade, Issues related to Small Business Innovation Research Program HOUSE OF REPRESENTATIVES,SENATE 45000   0 0 2023-04-17T10:30:46-04:00
2960811 FORBES-TATE b02765f7-1d3a-4568-89ab-dcc5f15d156d Q1 FORBES-TATE 400976792 AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION 2023 first_quarter MED Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2023-04-17T10:34:11-04:00
2960833 COMPASS GOVERNMENT RELATIONS PARTNERS, LLC 584a0660-0733-4318-ad0e-76449a0f7dcc Q1 COMPASS GOVERNMENT RELATIONS PARTNERS, LLC 401106533 COALITION FOR INNOVATIVE LABORATORY TESTING, INC. 2023 first_quarter MED VALID Act of 2021 (H.R.4128/S.2209; Provisions that negatively impact Clinical Laboratory Improvement Amendments (CLIA)-approved laboratory businesses; re-introduced in Spring of 2023 as H.R.2639 HOUSE OF REPRESENTATIVES,SENATE     0 0 2023-04-17T10:45:00-04:00
2960855 COMPASS MANAGEMENT PARTNERS, INC. 78dea111-b47f-4a88-9517-775899ee2f57 Q1 COMPASS MANAGEMENT PARTNERS, INC. 401105171 THE LIVING LEGACY FOUNDATION OF MARYLAND 2023 first_quarter MED Regulations impacting accountability requirements at organ procurement organizations; organ donation matters       0 0 2023-04-17T10:49:41-04:00
2960927 FORBES-TATE b9b09bc1-68f0-4182-b739-8c7f1022ae7f Q1 FORBES-TATE 400976792 AMGEN USA, INC. 2023 first_quarter MED Issues related to Biosimilars; Issues related to drug pricing; Issues related to H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169). HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2023-04-17T11:00:19-04:00
2961066 O'NEILL AND ASSOCIATES 3307ff14-5ff9-47f0-9865-3777c020ebdf Q1 O'NEILL AND ASSOCIATES 73134 POINT32HEALTH SERVICES, INC. (FORMERLY TUFTS HEALTH PLAN) 2023 first_quarter MED Healthcare, Medical HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2023-04-17T11:20:09-04:00
2961215 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) d97b0982-a0a6-4041-911b-22349328b2da Q1 FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) 86196 INTUITIVE SURGICAL, INC. 2023 first_quarter MED Lobbying related to health care issues. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2023-04-17T11:47:54-04:00
2961253 IMPACT MANAGEMENT GROUP c5a77d0d-1c67-46a8-b0f5-4307932dbcc0 Q1 IMPACT MANAGEMENT GROUP 401104137 CENTRAL ARKANSAS RADIATION THERAPY INSTITUTE, INC. 2023 first_quarter MED Supporting the passage of H.R. 3173 - Improving Seniors' Timely Access to Care Act of 2021 HOUSE OF REPRESENTATIVES     0 0 2023-04-17T11:53:56-04:00
2961257 FORBES-TATE ba81b86f-1295-41e4-a223-e0db04fda87c Q1 FORBES-TATE 400976792 CALIFORNIA LIFE SCIENCES ASSOCIATION 2023 first_quarter MED Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of H.R. 5376 - Inflation Reduction Act of 2022(P.L. 117-169). HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2023-04-17T11:54:08-04:00
2961357 BRAMER GROUP LLC 6cd88782-074b-4b17-b7c5-3262778b33cf Q1 BRAMER GROUP LLC 401103355 TACTICAL MEDICAL SOLUTIONS, LLC 2023 first_quarter MED FY2023 and FY2024 NDAA Army, Dept of (Other),Defense, Dept of (DOD) 8250   0 0 2023-04-17T12:11:25-04:00
2961398 FORBES-TATE b2c4520d-09fc-4f7f-95f3-91e033ef0c83 Q1 FORBES-TATE 400976792 COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION 2023 first_quarter MED Issues pertaining to government-wide federal regulation of cannabis. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2023-04-17T12:18:17-04:00
2961468 FORBES-TATE bbf202bc-aeef-47fc-8a53-cf394aa81a7b Q1 FORBES-TATE 400976792 CSL BEHRING 2023 first_quarter MED Issues related to Rx pricing. HOUSE OF REPRESENTATIVES,SENATE 120000   0 0 2023-04-17T12:30:02-04:00
2961542 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 2ef8add6-e89e-4895-91ad-d9745e17338f Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 DEFENSE HEALTH RESEARCH CONSORTIUM 2023 first_quarter MED FY24 Defense Appropriations Act, Defense Health Research Programs HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2023-04-17T12:48:02-04:00
2961572 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 72c6a468-501e-4589-ac8d-c0d20488656b Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 PANCREATIC CANCER ACTION NETWORK (PANCAN) 2023 first_quarter MED FY24 Defense Appropriations Act, Peer-Reviewed Pancreatic Cancer Research Program; FY24 Labor HHS Education Act, NIH research on pancreatic cancer HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2023-04-17T12:56:00-04:00
2961586 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 82e7df4f-2fb8-4bab-9f98-0ebdeda7353b Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 FOUNDATION FOR PERIPHERAL NEUROPATHY 2023 first_quarter MED FY24 Defense Appropriations Act, DoD funding for peripheral neuropathy research; FY24 Labor HHS Education Appropriations Act, NIH research on peripheral neuropathy HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2023-04-17T12:59:09-04:00
2961850 SQUIRE PATTON BOGGS a41f0d47-2f5b-4ee5-83a5-69b98bc8be39 Q1 SQUIRE PATTON BOGGS 30906 ALLIANCE FOR BIOSECURITY 2023 first_quarter MED Preparedness and response as it relates to Biosecurity. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 100000   0 0 2023-04-17T14:03:08-04:00
2961956 HACKENSACK MERIDIAN HEALTH 94d5951b-55f2-4fb1-9862-d32f4e8f4ceb Q1 HACKENSACK MERIDIAN HEALTH 401104109 HACKENSACK MERIDIAN HEALTH 2023 first_quarter MED National Institutes of Health funding Biomedical research and ARPA-H Support for the Center for Discovery and Innovation HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   160000 0 0 2023-04-17T14:36:31-04:00
2962059 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 378e7e3b-f658-428a-b1c5-9786f5d656c5 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 TUBEROUS SCLEROSIS ALLIANCE 2023 first_quarter MED FY24 Defense Appropriations Act, Tuberous Sclerosis Complex Research Program; FY24 Labor HHS Education Act, NIH and CDC funding for tuberous sclerosis complex research and surveillance. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2023-04-17T14:59:26-04:00
2962064 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. bb993eb5-873a-4fc0-9fb1-8188282611c5 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 KIDNEYCAN 2023 first_quarter MED FY24 Labor-HHS-Education Appropriations Act, kidney cancer research at NIH HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2023-04-17T15:01:03-04:00
2962078 AMERICAN PHYSICAL THERAPY ASSOCIATION 1849a360-29c0-4f22-8df6-52c18490d346 Q1 AMERICAN PHYSICAL THERAPY ASSOCIATION 3093 AMERICAN PHYSICAL THERAPY ASSOCIATION 2023 first_quarter MED NIH Rehab issues APTA role with NIH Traumatic brain injury research Support of work done at CDC Injury Center on elder adult falls, TBI, youth sports concussions NIH Research and Development funding PT role in childhood obesity Relocate TBI State Grant Program to ACL NIDILRR - Rehab research Nomination to NIH Committees Safety of Children in School (Restraint & Seclusion) Falls and Falls Prevention Outpatient Therapy Modernization and Stabilization Act Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   266282 0 0 2023-04-17T15:02:47-04:00
2962085 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 99d7fe78-a2fb-46f8-a40e-1b4405973530 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 VHL ALLIANCE 2023 first_quarter MED FY24 Defense Appropriations Act, DoD research on Von Hippel-Lindau syndrome; FY24 Labor HHS Education Act, NIH research on Von Hippel-Lindau syndrome. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2023-04-17T15:03:05-04:00
2962091 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. c5db8370-d2a6-419d-bfb2-a34b187a691b Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 VHL ALLIANCE 2023 first_quarter MED FY24 Defense Appropriations Act, DoD research on Von Hippel-Lindau syndrome; FY24 Labor HHS Education Act, NIH research on Von Hippel-Lindau syndrome. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2023-04-17T15:04:56-04:00
2962566 SQUIRE PATTON BOGGS b7fc39f8-47ec-496c-9db3-519e2a77c5b8 Q1 SQUIRE PATTON BOGGS 30906 LA MAESTRA FOUNDATION ON BEHALF OF LA MAESTRA FAMILY CLINIC, INC. 2023 first_quarter MED Funding support for federally qualified health centers; reauthorization of programs HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2023-04-17T16:46:36-04:00
2962693 AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS 5cb4c6cd-4340-4d9b-a9ac-a0c53d3d74a4 Q1 AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS 52105 AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS 2023 first_quarter MED Support appropriations for the Peer-Reviewed Orthopaedic Research Program (PRORP). PRORP is a competitive grant program that funds research pertaining to extremity war injuries HOUSE OF REPRESENTATIVES,SENATE   431429 0 0 2023-04-17T17:17:12-04:00
2962762 VARIAN MEDICAL SYSTEMS, INC. 06c81031-65cd-4a32-af17-d148680058a8 Q1 VARIAN MEDICAL SYSTEMS, INC. 400359648 VARIAN MEDICAL SYSTEMS, INC. 2023 first_quarter MED Right to Repair Artificial Intelligence for Medical Devices Health care workforce PACT Act Physician Fee Schedule/Reimbursement Issues HOUSE OF REPRESENTATIVES,SENATE   240000 0 0 2023-04-17T17:48:21-04:00
2962961 CAPITOL COUNSEL LLC 38ee7760-3dd9-4a34-82b4-ab3aa76db7ce Q1 CAPITOL COUNSEL LLC 313715 BLUE EARTH DIAGNOSTICS, INC. 2023 first_quarter MED To gain support for adequate Medicare reimbursement for diagnostic radiopharmaceuticals; H.R.1199 - Facilitating Innovative Nuclear Diagnostics Act of 2023. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2023-04-17T21:12:02-04:00
2962969 CAPITOL COUNSEL LLC 31fd640c-ddbc-4843-ae02-52d606aaadc8 Q1 CAPITOL COUNSEL LLC 313715 EMD SERONO, INC. 2023 first_quarter MED Issues regarding the availability and pricing of prescription drugs. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2023-04-17T21:25:23-04:00
2962997 CAPITOL COUNSEL LLC 388bdd11-f24d-4085-99f1-ff2da07bd672 Q1 CAPITOL COUNSEL LLC 313715 MASSACHUSETTS BIOTECHNOLOGY COUNCIL 2023 first_quarter MED Monitor health and tax legislation pertaining to the biotechnology industry. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2023-04-17T22:05:24-04:00
2963059 CORNERSTONE GOVERNMENT AFFAIRS, INC. a88c4477-2cc4-45f4-9057-99cd7cdb27e6 Q1 CORNERSTONE GOVERNMENT AFFAIRS, INC. 75557 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION 2023 first_quarter MED Congressional outreach related to health care issues. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2023-04-17T23:27:53-04:00
2963314 BLUEBIRD STRATEGIES 2a83cbd8-437c-4bf2-99fd-71868810c832 Q1 BLUEBIRD STRATEGIES 401105447 MYRIAD GENETICS, INC. 2023 first_quarter MED Legislation to regulate clinical labs under CLIA and FDA. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2023-04-18T09:27:57-04:00
2963334 BLUEBIRD STRATEGIES 5464273d-8432-4f29-9a4b-11c0213f8a03 Q1 BLUEBIRD STRATEGIES 401105447 MYOTONIC 2023 first_quarter MED Increasing funding for Myotonic Dystrophy research. Fiscal Year 2024 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE     0 0 2023-04-18T09:36:04-04:00
2963574 MICHIGAN TECHNOLOGICAL UNIVERSITY 346e28eb-7dc7-4c25-9126-4c52e7ffe585 Q1 MICHIGAN TECHNOLOGICAL UNIVERSITY 25181 MICHIGAN TECHNOLOGICAL UNIVERSITY 2023 first_quarter MED Discussed issues of interest related to higher education for the COVID-19 pandemic. HOUSE OF REPRESENTATIVES,SENATE   60000 0 0 2023-04-18T10:33:12-04:00
2963576 BARKER LEAVITT, PLLC (SKA MR. JAMES C. BARKER) 3b73b80f-f255-479b-8f25-e7d37837b75f Q1 BARKER LEAVITT, PLLC (SKA MR. JAMES C. BARKER) 292538 SONIC HEALTHCARE USA 2023 first_quarter MED Issues relating to the regulation of laboratory developed tests, the VALID Act, issues relating to PAMA (the SALSA Bill), federal policies relating to the implementation of the anti-kickback requirements of the Support for Patients and Communities Act. Physician Lab Fee schedule. Anatomic Fee Schedule and Surprise Billing. COVID Testing and billing procedures. COVID Vaccine Federal Mandate. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2023-04-18T10:33:24-04:00
2964198 BECKER & POLIAKOFF, P.A. 09d31607-7ada-4781-aba8-1ce3e731d626 Q1 BECKER & POLIAKOFF, P.A. 283696 UNIVERSITY OF MIAMI 2023 first_quarter MED Cancer Research Grants Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2023-04-18T12:35:21-04:00
2964351 STRATEGIC MARKETING INNOVATIONS d7e89502-7b81-4f82-8656-86f22d5bab36 Q1 STRATEGIC MARKETING INNOVATIONS 60550 ICHOR SCIENCES 2023 first_quarter MED Defense appropriations programmatic add Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2023-04-18T13:15:59-04:00
2964599 POWERS PYLES SUTTER & VERVILLE, P.C. 5eeb7015-fcd4-4725-b1c5-f864fcb491a7 Q1 POWERS PYLES SUTTER & VERVILLE, P.C. 32008 HERBERT J. THOMAS MEMORIAL HOSPITAL ASSOCIATION (FKA THOMAS HEALTH) 2023 first_quarter MED Consolidated Appropriations Act, FY 2022, H.R. 2741, now P.L. 117-103 (FY 2022 CDS Implementation) FY 2024 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2024 House, Senate Department of Agriculture Appropriations Bills FY 2024 House, Senate Department of Commerce and Justice, Science and Related Appropriations Bills FY 2024 House, Senate Department of Homeland Security Appropriations Bills FY 2024 House, Senate Financial Services and General Government Appropriations Bills FY 2024 House, Senate Departments of Transportation, Housing and Urban Development and Related Agencies Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Legislation to Train More Primary Care, Behavioral Health and Related Providers House, Senate Legislation to Fund Substance Use Disorder Prevention and Treatment House, Senate Legislation to Fund Behavioral Health Programs House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Legislation to Implement Electronic Provider Consultations (E-Consults) with Related Telemedicine/Telehealth in Hospitals House, Senate Infrastructure Bills Administration for Children & Families (ACF),Administration on Aging,Agency for Healthcare Research & Quality (AHRQ),Agriculture, Dept of (USDA),Appalachian Regional Commission,Bureau of Labor Statistics (BLS),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Economic Development Administration,Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),Treasury, Dept of 30000   0 0 2023-04-18T14:02:32-04:00
2964699 POWERS PYLES SUTTER & VERVILLE, P.C. cd1c75ba-cf3f-4f26-a8aa-bdc841030c6d Q1 POWERS PYLES SUTTER & VERVILLE, P.C. 32008 CORNERSTONE CARE, INC. 2023 first_quarter MED Consolidated Appropriations Act, 2023, H.R. 2617, now P.L. 117-328 FY 2024 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2024 House, Senate Department of Agriculture Appropriations Bills FY 2024 House, Senate Department of Homeland Security Appropriations Bills FY 2024 House, Senate Commerce and Justice, Science and Related Agencies Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Legislation to Train More Primary Care and Other Providers House, Senate Legislation to Fund Substance Use Disorder and Behavioral Health Programs House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Infrastructure Bills Appalachian Regional Commission,Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Economic Development Administration,Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),Treasury, Dept of     0 0 2023-04-18T14:18:06-04:00
2964783 BROWNSTEIN HYATT FARBER SCHRECK, LLP be731535-2d4b-413c-8fd4-16bd215b9700 1T BROWNSTEIN HYATT FARBER SCHRECK, LLP 7257 COLUMBIA CARE LLC 2023 first_quarter MED Issues relating to cannabis research, including the DEA August 12, 2016, solicitation of applications to manufacture cannabis for research purposes (Docket No. DEA-447) HOUSE OF REPRESENTATIVES,SENATE 10000   0 1 2023-04-18T14:33:33-04:00
2964999 GOLDBUG STRATEGIES LLC c79088c2-0e93-4fdc-86bf-528ed244b0f7 Q1 GOLDBUG STRATEGIES LLC 400701094 COALITION FOR 21ST CENTURY MEDICINE 2023 first_quarter MED in vitro diagnostics, clinical laboratories, digital health regulation Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE     0 0 2023-04-18T15:17:37-04:00
2965013 WASHINGTON UNIVERSITY IN ST. LOUIS a4d32522-e54d-4a07-9326-5bdb3705ec03 Q1 WASHINGTON UNIVERSITY IN ST. LOUIS 40031264 WASHINGTON UNIVERSITY IN ST LOUIS 2023 first_quarter MED General advocacy for NIH and other biomedical research. General advocacy supporting the continued responsible utilization of research animals. HOUSE OF REPRESENTATIVES,SENATE   10000 0 0 2023-04-18T15:21:52-04:00
2965050 WIDERCHANGE LLC 50ed654a-5da6-475f-ab23-991fe5bb7b54 1A WIDERCHANGE LLC 401107228 PHOENIX ZONES INITIATIVE 2023 first_quarter MED HR 1024 Humane and Existing Alternatives in Research and Testing Sciences Act of 2022 or the HEARTS Act of 2022 and issues related to the FDA Modernization Act of 2021. Brief conversations with staff members discussed patient benefits of modernize medical testing. HOUSE OF REPRESENTATIVES,SENATE     0 0 2023-04-18T15:31:20-04:00
2965093 POWERS PYLES SUTTER & VERVILLE, P.C. 81bbb75b-633c-4f07-8919-d1b13a05d44e Q1 POWERS PYLES SUTTER & VERVILLE, P.C. 32008 GATEWAYS HOSPITAL & MENTAL HEALTH CENTER FOUNDATION 2023 first_quarter MED Consolidated Appropriations Act, 2023, H.R. 2617, now P.L. 117-328 FY 2024 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2024 House, Senate Department of Agriculture Appropriations Bills FY 2024 House, Senate Department of Commerce and Justice, Science and Related Appropriations Bills FY 2024 House, Senate Department of Homeland Security Appropriations Bills FY 2024 House, Senate Financial Services and General Government Appropriations Bills FY 2024 House, Senate Departments of Transportation, Housing and Urban Development and Related Agencies Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Legislation to Train More Behavioral Health and Related Providers House, Senate Legislation to Fund Substance Use Disorder Prevention and Treatment House, Senate Legislation to Fund Behavioral Health Care Programs House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Infrastructure Bills Administration for Children & Families (ACF),Agency for Healthcare Research & Quality (AHRQ),Agriculture, Dept of (USDA),Bureau of Justice Assistance,Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Justice, Dept of (DOJ),Office of Justice Program,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) 20000   0 0 2023-04-18T15:40:50-04:00
2965242 STANFORD UNIVERSITY 2bef9286-898e-4c25-853a-b73b4bbd5f9d Q1 STANFORD UNIVERSITY 36492 STANFORD UNIVERSITY 2023 first_quarter MED Issues related to health equity and social determinants of health HR 2389 Resident Physician Shortage Reduction Act of 2023 HR 459 - SAFER Health Act Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   90000 0 0 2023-04-18T15:54:28-04:00
2965299 POWERS PYLES SUTTER & VERVILLE, P.C. af0a98f7-4ab8-405f-a0b7-a21fca4f555f Q1 POWERS PYLES SUTTER & VERVILLE, P.C. 32008 PIH HEALTH FOUNDATION 2023 first_quarter MED Consolidated Appropriations Act, 2023, H.R. 2617, now P.L. 117-328 FY 2024 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2024 House, Senate Department of Agriculture Appropriations Bills FY 2024 House, Senate Commerce and Justice, Science and Related Agencies Appropriations Bills FY 2024 House, Senate Financial Services and General Government Appropriations Bills FY 2024 House, Senate Department of Homeland Security Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Legislation to Train More Primary Care and Other Providers House, Senate Legislation to Fund Substance Use Disorder and Behavioral Health Programs House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Legislation to Implement Electronic Provider Consultations(E-Consults) with Related Telemedicine in Hospitals House, Senate Infrastructure Bills Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) 30000   0 0 2023-04-18T16:05:57-04:00
2965731 TWENTY-FIRST CENTURY GROUP, INC. 2d355787-a3fc-451f-93bf-c1a25ab0f7c4 Q1 TWENTY-FIRST CENTURY GROUP, INC. 38687 GLOBAL ALZHEIMER'S PLATFORM INNOVATIONS PBC 2023 first_quarter MED Issues related to diversity in clinical trials and Alzheimers research. HOUSE OF REPRESENTATIVES,SENATE 24000   0 0 2023-04-18T17:10:36-04:00
2965750 TWENTY-FIRST CENTURY GROUP, INC. 8e469d4f-0538-4d13-af44-9dc789ca1ff3 Q1 TWENTY-FIRST CENTURY GROUP, INC. 38687 NRX PHARMACEUTICALS INC (FORMERLY KNOWN AS NEURORX) 2023 first_quarter MED Research and treatment related to suicide prevention for veterans and patients with bipolar depression. HOUSE OF REPRESENTATIVES,SENATE 24000   0 0 2023-04-18T17:15:44-04:00
2965889 THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) 90ff8e06-f1c6-458f-91be-678ab9fe17d9 Q1 THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) 2970 THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) 2023 first_quarter MED none     160000 0 0 2023-04-18T17:46:36-04:00
2965959 ARENTFOX SCHIFF LLP 0610986b-303c-43da-8ecf-cc29d6111271 Q1 ARENTFOX SCHIFF LLP 4208 INFECTIOUS DISEASES SOCIETY OF AMERICA 2023 first_quarter MED Draft legislation (PASTEUR Act), all provisions HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2023-04-18T18:10:52-04:00
2966065 OAK RIDGE ASSOCIATED UNIVERSITIES, INC. ef383513-f7b8-4c36-a9c3-9c7df8cf0e8e Q1 OAK RIDGE ASSOCIATED UNIVERSITIES, INC. 401104196 OAK RIDGE ASSOCIATED UNIVERSITIES, INC. 2023 first_quarter MED FY24 HHS / CDC Appropriations Health & Human Services, Dept of (HHS)   30000 0 0 2023-04-18T18:30:23-04:00
2966467 BROWNSTEIN HYATT FARBER SCHRECK, LLP 012c48fe-0a63-43b5-9948-95312fc13bbc Q1 BROWNSTEIN HYATT FARBER SCHRECK, LLP 7257 MARIDOSE LLC 2023 first_quarter MED Issues relating to cannabis research, including the DEA Aug. 12 2016 solicitation of applications to manufacture cannabis for research purposes (Docket No. DEA-447) Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE     0 0 2023-04-18T23:03:16-04:00
2966663 STRATEGIC MARKETING INNOVATIONS 8bf2077a-2aac-4d81-bf08-d9478f2b8011 Q1 STRATEGIC MARKETING INNOVATIONS 60550 PSYONIC 2023 first_quarter MED Receive DoD medical research funding on how to best apply prosthetic to the nervous system Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2023-04-19T08:08:18-04:00
2966708 BOLD STRATEGIES, LLC 0b7c3b7d-129a-4114-bc30-4c49fbdcd140 Q1 BOLD STRATEGIES, LLC 401104653 PENNINGTON BIOMEDICAL RESEARCH CENTER 2023 first_quarter MED Obesity and COVID research. Appropriations. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2023-04-19T08:39:22-04:00
2967218 UNIVERSITY OF IOWA 8a403bd0-f390-4027-bc89-1e9be69000d5 Q1 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2023 first_quarter MED Support for robust funding for federal agencies that fund medical and disease research HOUSE OF REPRESENTATIVES,SENATE   50000 0 0 2023-04-19T10:06:02-04:00
2967460 PARALYZED VETERANS OF AMERICA 06d3020d-454e-4f2e-b0bd-a6ecca3b7487 Q1 PARALYZED VETERANS OF AMERICA 30724 PARALYZED VETERANS OF AMERICA 2023 first_quarter MED Discussions: Department of Veterans Affairs, Medical Research Issues Discussions: National Institutes of Health, Medical Research Issues HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA)   88885 0 0 2023-04-19T10:25:30-04:00
2967562 TURNER & GOSS LLP 5214cc8c-7747-498d-886c-5efcde6ae459 Q1 TURNER & GOSS LLP 316310 CYSTIC FIBROSIS FOUNDATION 2023 first_quarter MED PASTEUR Act (HR 3932 and S 2076 in previous Congress; to be reintroduced) HOUSE OF REPRESENTATIVES,SENATE     0 0 2023-04-19T10:34:30-04:00
2967814 STRATEGIES 360 d559fa7b-dc62-462c-86c2-dba211a7328a Q1 STRATEGIES 360 79175 INNOVA MEDICAL GROUP, INC. 2023 first_quarter MED Issues related to the FDA approval process for medical testing   30000   0 0 2023-04-19T10:51:51-04:00
2968066 VAN SCOYOC ASSOCIATES ca9daedc-8490-4013-a04f-77f35f04edf6 Q1 VAN SCOYOC ASSOCIATES 39837 ARUP LABORATORIES, INC. 2023 first_quarter MED H.R.2369, To amend the Federal Food, Drug, and Cosmetic Act with respect to in vitro clinical tests, and for other purposes, Diagnostic Lab Testing Laboratory Testing related issues Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues Clinical Laboratory Improvement Amendments (CLIA), generally Pandemic All Hazards Preparedness Act, generally Monitor CURES 2.0, Diagnostic Lab Testing issues HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2023-04-19T11:11:09-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 1849.314ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API